Publications by authors named "Israel Henig"

Claim this Profile
C
CCR5 predicts neurotoxicity in CAR-T-cell therapy.
Ayal Rozenberg, Shahar Shelly, Raz Winer, Riva Fineman, Shani Haller, Israel Henig

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Mayasa Abu Ata, Israel Henig, Dana Yehudai-Ofir, Inna Tzoran, Shimrit Ringelstein-Harlev

Acta Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approach.
Shiri Keret, Boris Chutko, Idit Dobrecky-Mery, Arik Wolak, Emilia Hardak, Israel Henig

Rheumatology (Oxford)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.
Anat Stern, Israel Henig, Maya Cohen, Ivan Gur, Oryan Henig

J Antimicrob Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Eitan Kugler, Inbar Cohen, Irina Amitai, Ron Ram, Avraham Frisch, Israel Henig

Br J Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor-T cell therapy.
Jabour Halloun, Itay Maza, Anat Stern, Israel Henig, Luiza Akria

J Cell Mol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
Shiri Keret, Israel Henig, Tsila Zuckerman, Lisa Kaly, Aniela Shouval

Rheumatology (Oxford)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Ilan Youngster, Adi Eshel, Mika Geva, Ivetta Danylesko, Israel Henig

Bone Marrow Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete resolution of gastric antral vascular ectasia after autologous haematopoietic stem cell transplantation in systemic sclerosis.
Shiri Keret, Tsila Zuckerman, Israel Henig, Tova Rainis, Safwat Odeh

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev

Vaccines (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.
Keisuke Seike, Anders Kiledal, Hideaki Fujiwara, Israel Henig, Marina Burgos da Silva

Immunity· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig

Ann Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig

Ann Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin.
Tareq Artul, Israel Henig, Laila Nassar, Dana Yehudai-Ofir, Inna Scherb

Ther Drug Monit· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
Haneen Daoud-Asfour, Israel Henig, Itai Ghersin, Stav Rakedzon, Anat Stern

Transplant Cell Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis.
Adi Eshel, Itai Sharon, Arnon Nagler, David Bomze, Ivetta Danylesko, Israel Henig

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.
Israel Henig, Dana Yehudai-Ofir, Yaniv Zohar, Tsila Zuckerman

Acta Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-COV-2 vaccination after stem cell transplantation for scleroderma.
Doron Rimar, Gleb Slobodin, Alona Paz, Israel Henig, Tsila Zuckerman

Ann Rheum Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Israel Henig, Dana Yehudai-Ofir, Tsila Zuckerman

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies as a regulator of T cell alloimmunity.
Daniel Peltier, Molly Radosevich, Visweswaran Ravikumar, Sethuramasundaram Pitchiaya, Thomas Decoville, Israel Henig

Sci Transl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
Yishai Ofran, Ronit Leiba, Avraham Frisch, Nurit Horesh, Israel Henig

Eur J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant B cells, autoimmunity and the benefit of targeting B cells in chronic graft-versus-host disease.
Dana Yehudai-Ofir, Israel Henig, Tsila Zuckerman

Autoimmun Rev· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.
Yishai Ofran, Shimrit Ringelstein-Harlev, Ilana Slouzkey, Tsila Zuckerman, Dana Yehudai-Ofir, Israel Henig

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Yishai Ofran, Michal Hayun, Ronit Leiba, Tsila Zuckerman, Netanel Horowitz, Israel Henig

Am J Hematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.
Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren-Michowitz, Ron Hoffman, Israel Henig

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis